| Primary |
| Colorectal Cancer Metastatic |
31.4% |
| Product Used For Unknown Indication |
15.4% |
| Metastatic Neoplasm |
7.7% |
| Neoplasm |
7.7% |
| Colorectal Cancer |
7.1% |
| Metastatic Colon Cancer |
3.8% |
| Metastatic Colorectal Cancer |
3.8% |
| Colon Cancer |
3.2% |
| Colon Cancer Metastatic |
3.2% |
| Drug Use For Unknown Indication |
3.2% |
| Hypertension |
2.6% |
| Pain |
2.6% |
| Blood Pressure |
1.9% |
| Metastatic Gastric Cancer |
1.9% |
| Carcinoid Tumour |
1.3% |
| Metastatic Colorectal Cancer |
0.6% |
| Arthralgia |
0.6% |
| Arthritis |
0.6% |
| Carcinoid Tumour Of The Caecum |
0.6% |
| Colon Cancer Stage Iv |
0.6% |
|
| Death |
8.3% |
| Sepsis |
8.3% |
| Stomatitis |
8.3% |
| Diarrhoea |
6.3% |
| Disease Progression |
6.3% |
| Hypertension |
6.3% |
| Proteinuria |
6.3% |
| Thrombocytopenia |
6.3% |
| Vomiting |
6.3% |
| Adverse Event |
4.2% |
| Dyspnoea |
4.2% |
| Mucosal Inflammation |
4.2% |
| Neutropenia |
4.2% |
| Pyrexia |
4.2% |
| Skin Discolouration |
4.2% |
| Subarachnoid Haemorrhage |
4.2% |
| Abdominal Pain Upper |
2.1% |
| Accidental Exposure To Product |
2.1% |
| Anal Ulcer |
2.1% |
| Angiopathy |
2.1% |
|
| Secondary |
| Colorectal Cancer Metastatic |
30.1% |
| Product Used For Unknown Indication |
22.9% |
| Metastatic Neoplasm |
8.2% |
| Neoplasm |
8.2% |
| Colon Cancer Metastatic |
7.5% |
| Colon Cancer |
6.2% |
| Colorectal Cancer |
4.1% |
| Metastatic Colon Cancer |
2.1% |
| Metastatic Gastric Cancer |
2.1% |
| Anaemia |
1.4% |
| Metastatic Colorectal Cancer |
1.4% |
| Lung Neoplasm Malignant |
1.0% |
| Pain |
1.0% |
| Constipation |
0.7% |
| Epilepsy |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Hypertension |
0.7% |
| Metastatic Colorectal Cancer |
0.3% |
| Diabetes Mellitus |
0.3% |
| Metastasis |
0.3% |
|
| Osteonecrosis Of Jaw |
11.5% |
| Cerebral Haemorrhage |
8.2% |
| Sepsis |
8.2% |
| Vomiting |
8.2% |
| Disease Progression |
4.9% |
| Hypersensitivity |
4.9% |
| Hypertension |
4.9% |
| Neutropenia |
4.9% |
| Pyrexia |
4.9% |
| Stomatitis |
4.9% |
| Transient Ischaemic Attack |
4.9% |
| Blood Pressure Increased |
3.3% |
| Colitis |
3.3% |
| Diarrhoea |
3.3% |
| Haemorrhage |
3.3% |
| Intestinal Perforation |
3.3% |
| Oedema Peripheral |
3.3% |
| Proteinuria |
3.3% |
| Rash |
3.3% |
| Skin Exfoliation |
3.3% |
|
| Interacting |
| Colorectal Cancer |
60.0% |
| Arthralgia |
20.0% |
| Product Used For Unknown Indication |
20.0% |
|
|
